insights_auto
Why is ORX down 16,73%?
Dive Deeperchevron_right
ORX:STO
Orexo AB
0,87 SEK
arrow_downward
-16,73%(-0,17) 1D
12-ноя., 17:29:50 GMT+1 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ORX...
Open
1,04 SEK
High
1,05 SEK
Low
0,80 SEK
Mkt. cap
304,20 млн
Avg. vol.
613,79 миң
Volume
3,83 млн
P/E ratio
0,04
52-wk high
22,55 SEK
52-wk low
0,80 SEK
EPS
21,73 SEK
Shares outstanding
35,13 млн
No. of employees
55
Open
1,04 SEK
High
1,05 SEK
Low
0,80 SEK
Mkt. cap
304,20 млн
Avg. vol.
613,79 миң
Volume
3,83 млн
P/E ratio
0,04
52-wk high
22,55 SEK
52-wk low
0,80 SEK
EPS
21,73 SEK
Shares outstanding
35,13 млн
No. of employees
55
News stories
From web sources and news partners
Yahoo Finance
·
32 мүнөт мурун
Dow, S&P 500, Nasdaq Futures Edge Higher As Markets Attempt To Recover From Nvidia Rout: SLS, MSFT, CADL, MSTR In Focus
Eurasia Business News
·
4 саат мурун
Stock Market Today, November 12, 2026: Dow, S&P 500 and Nasdaq Fall After Jensen Huang Resigns
ChartMill
·
8 саат мурун
Most Active S&P 500 Stocks: KDP, Ford, AT&T Lead Today's Session
Traders Union
·
5 саат мурун
Jake Wujastyk: S&P 500 and ES_F trade within last Thursday's range for a full week
Profile
Orexo is a Swedish pharmaceutical company that develops improved pharmaceuticals based on innovative formulation technologies that meet large medical needs. Through presence its in the US market, drugs and digital therapies are commercialized to treat opioid use disorder and adjacent diseases. Products targeting other therapeutic areas are developed and commercialized worldwide with partners. Wikipedia
About Orexo AB
CEONikolaj Sørensen
Employees55
Founded1995
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websiteorexo.com